(Q28218133)

English

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients

scientific article (publication date: June 2006)

In more languages

Statements

scholarly article

0 references

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

author name string

T Ohmori

1

0 references

Y Yatomi

2

0 references

T Nonaka

3

0 references

Y Kobayashi

4

0 references

S Madoiwa

5

0 references

J Mimuro

6

0 references

Y Ozaki

7

0 references

Y Sakata

8

0 references

language of work or name

0 references

publication date

June 2006

0 references

Journal of Thrombosis and Haemostasis

0 references

4

0 references

6

0 references

1271-8

0 references

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2006.01958.X

20 April 2017

Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2006.01958.X

20 April 2017

Aspirin resistance and atherothrombotic disease

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2006.01958.X

20 April 2017

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2006.01958.X

20 April 2017

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2006.01958.X

20 April 2017

Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2006.01958.X

20 April 2017

Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2006.01958.X

20 April 2017

Genetic variation in cyclooxygenase 1: effects on response to aspirin

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2006.01958.X

20 April 2017

Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2006.01958.X

20 April 2017

Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2006.01958.X

20 April 2017

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2006.01958.X

20 April 2017

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28218133&oldid=1233291213"